|
| O |
|
Octreotide Acetate |
|
| Injection, Ampule : 0.1mg/mL ; 0.5mg/mL |
Biologicals |
| Biologicals |
|
|
|
|
|
Octreotide Acetate |
|
|
Injection, Ampule
: 0.1mg/mL; 0.5mg/mL
|
Hormone & Related Drugs |
| Pituitary Hormone & Antagonist |
|
|
|
|
|
Ofloxacin |
|
| Injection, Solution : 200mg |
|
Oral, Tablet
: 200mg; 400mg
|
| solution, vial : 2mg/ml, 100ml |
Anti-infectives |
| Quinolones |
|
|
|
|
|
Ofloxacin |
|
|
Opthalmic, Drop
: 3mg /mL x 5mL;
|
Opthalmic Preparations |
| Opthalmic Preparations |
|
|
|
|
|
Omeprazole |
|
|
Injection, Vial
: 40mg
|
|
Oral, Capsule
: 20mg; 40mg
|
Gastrointestinal & Hepatobiliary Drugs |
| Hyper Acidity, Acid Reflux & Peptic Ulcer Disease (proton Pump Inhibitor) ; Hyper Acidity, Acid Reflux & Peptic Ulcer Disease (cytoprotective, Gastrointestinal) |
|
|
|
|
|
Ondansetron |
|
|
Injection, Vial
: 2mg /mL x 2mL; 2mg /mL x 4mL
|
|
tablet
: 8mg
|
Neuropsychiatric Drugs |
| Anti-emetic/vertigo |
|
|
|
|
|
Oral Rehydrating Solution |
|
|
Oral, Granules For Solution
: NaCl 520 mg, KCl 300 mg, trisodium citrate dihydrate 580 mg, anhydrous glucose 2.7 g
|
|
Oral, Solution
: 45mEq Na + 20mEq K +35mEq Cl +30mEq citrate + 25g Dextrose
|
Nutritional, Fluid & Electrolyte Products |
| Nutritional, Fluid & Electrolyte Products |
|
|
|
|
|
Oxacillin |
|
|
Injection, Vial
: 500mg
|
Anti-infectives |
| Penicillin |
|
|
|
|
|
Oxcarbazepine |
|
|
Oral, Tablet
: 300mg; 600mg
|
Neuropsychiatric Drugs |
| Anti-convulsant |
|
|
|
|
|
Oxycodone |
|
|
Iv, Ampule
: 10mg/mL, 1ml
20mg/2ml
|
|
Oral, Capsule
: 5mg; 10mg
|
|
Oral, Tablet
: 5mg; 10mg; 20mg; 40mg
|
Analgesics, Anti-pyretics And Anti-inflammatory Drugs |
| Opiates And Antagonist |
|
|
|
|
|
Oxymetazoline |
|
|
Nasal, Drops
: 0.03% x 15ml
|
|
Nasal, Spray
: 0.05% x 15mL;
0.05% x 10ml
|
Respiratory Drugs |
| Nasal Decongestant |
|
|
|
|
|
Oxytocin |
|
|
Injection, Ampule
: 10IU x 1mL
|
Urogenital & Uterine Drugs |
| Uterine Stimulant |
|
|
|
|
|
OBINUTUZUMAB |
|
| VIAL : 1000MG/40ML |
Anti-cd20 Monoclonal Antibody |
| Antineoplastic |
|
|
|
|